Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2017

Mar 16, 2017

32870_dirs_2017-03-16_076825d5-6dc4-4ba9-86fe-6057049cc368.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-03-15

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-15 Common Stock G 1800 $0.00 Disposed 37465 Direct

Footnotes

F1: This transaction involved a gift of issuer common stock by the reporting person to a charitable gift fund.